Announcements Trials

Browse Landscape

Phase

Phase 3 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1

Interventions

Oxaliplatin 11 Docetaxel 8 Fluorouracil 6 Capecitabine 6 Leucovorin 5 Drug Therapy 5 apatinib 4 Trastuzumab 4 S 1 (combination) 4 Tegafur 3 Paclitaxel 3 Nivolumab 3 Irinotecan 3 Cisplatin 3 sintilimab 2 disitamab vedotin 2 Surgical Procedures, Operative 2 Standard of Care 2 Ramucirumab 2 Hyperthermic Intraperitoneal Chemotherapy 2 Epirubicin 2 vinflunine 1 toripalimab 1 titanium silicide 1 tislelizumab 1 taxane 1 polysaccharide-K 1 pertuzumab 1 margetuximab 1 gimeracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Stomach Neoplasms × polysaccharide-K × Clear all

NCT00503321 2009-01-23

eNCIT-Japan

Eastern Network of Cancer Immunological Therapy, Japan

Phase 2/3 Terminated

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡